Inverse relationship of serum adiponectin concentration with type 2 diabetes mellitus incidence in middle-aged Japanese workers: Six-year follow-up

Diabetes/Metabolism Research and Reviews

Volumn 28, Issue 4, 2012, Pages 349-356

  Li, Yuanying ^a,b   Yatsuya, Hiroshi ^b   Iso, Hiroyasu ^a   Toyoshima, Hideaki ^c   Tamakoshi, Koji ^d  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c ANJO KOSEI HOSPITAL   (Japan)

^d NAGOYA UNIVERSITY   (Japan)

Author keywords

Adiponectin; Japanese; Longitudinal study; Type 2 diabetes

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CONFOUNDING VARIABLE; CORRELATION COEFFICIENT; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; INCIDENCE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; JAPANESE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SELF REPORT; SMOKING;

ADIPONECTIN; ADULT; AGE FACTORS; AGED; BLOOD GLUCOSE; C-REACTIVE PROTEIN; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INCIDENCE; INSULIN; JAPAN; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; SEX FACTORS;

EID: 84860910449     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.2277     Document Type: Article

References (32)

1. Ukkola O, Santaniemi M. Adiponectin: a link between excess adiposity and associated comorbidities? J Mol Med 2002; 80(11): 696-702.
2. Berg AH, Combs TP, Du X, Brownlee M, Scherer PE. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 2001; 7(8): 947-953.
3. Fruebis J, Tsao TS, Javorschi S, et al. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci USA 2001; 98(4): 2005-2010.
4. Rabe K, Lehrke M, Parhofer KG, Broedl UC. Adipokines and insulin resistance. Mol Med 2008; 14(11-12): 741-751.
5. Yamauchi T, Kamon J, Waki H, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001; 7(8): 941-946.
6. Cnop M, Havel PJ, Utzschneider KM, et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 2003; 46(4): 459-469.
7. Hanley AJ, Bowden D, Wagenknecht LE, et al. Associations of adiponectin with body fat distribution and insulin sensitivity in nondiabetic Hispanics and African-Americans. J Clin Endocrinol Metab 2007; 92(7): 2665-2671.
8. Saltevo J, Laakso M, Jokelainen J, Keinanen-Kiukaanniemi S, Kumpusalo E, Vanhala M. Levels of adiponectin, C-reactive protein and interleukin-1 receptor antagonist are associated with insulin sensitivity: a population-based study. Diabetes Metab Res Rev 2008; 24(5): 378-383.
9. Bacha F, Saad R, Gungor N, Arslanian SA. Adiponectin in youth: relationship to visceral adiposity, insulin sensitivity, and beta-cell function. Diabetes Care 2004; 27(2): 547-552.
10. Hivert MF, Sullivan LM, Fox CS, et al. Associations of adiponectin, resistin, and tumor necrosis factor-alpha with insulin resistance. J Clin Endocrinol Metab 2008; 93(8): 3165-3172.
11. Matsushita K, Yatsuya H, Tamakoshi K, et al. Comparison of circulating adiponectin and proinflammatory markers regarding their association with metabolic syndrome in Japanese men. Arterioscler Thromb Vasc Biol 2006; 26(4): 871-876.
12. Wang Z, Zhuo Q, Fu P, et al. Are the associations of plasma leptin and adiponectin with type 2 diabetes independent of obesity in older Chinese adults? Diabetes Metab Res Rev 2010; 26(2): 109-114.
13. Daimon M, Oizumi T, Saitoh T, et al. Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese population: the Funagata study. Diabetes Care 2003; 26(7): 2015-2020.
14. Duncan BB, Schmidt MI, Pankow JS, et al. Adiponectin and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes 2004; 53(9): 2473-2478.
15. Ley SH, Harris SB, Connelly PW, et al. Adipokines and incident type 2 diabetes in an Aboriginal Canadian population: the Sandy Lake Health and Diabetes Project. Diabetes Care 2008; 31(7): 1410-1415.
16. Nakashima R, Kamei N, Yamane K, Nakanishi S, Nakashima A, Kohno N. Decreased total and high molecular weight adiponectin are independent risk factors for the development of type 2 diabetes in Japanese-Americans. J Clin Endocrinol Metab 2006; 91(10): 3873-3877.
17. Conroy SM, Chai W, Lim U, Franke AA, Cooney RV, Maskarinec G. Leptin, adiponectin, and obesity among Caucasian and Asian women. Mediators Inflamm 2011; 2011: 253580.
18. Kadowaki T, Sekikawa A, Okamura T, et al. Higher levels of adiponectin in American than in Japanese men despite obesity. Metabolism 2006; 55(12): 1561-1563.
19. Huxley R, James WP, Barzi F, et al. Ethnic comparisons of the cross-sectional relationships between measures of body size with diabetes and hypertension. Obes Rev 2008; 9(Suppl 1): 53-61.
20. Wada K, Yatsuya H, Ouyang P, et al. Self-reported medical history was generally accurate among Japanese workplace population. J Clin Epidemiol 2009; 62(3): 306-313.
21. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28(7): 412-419.
22. Kim JY, van de Wall E, Laplante M, et al. Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J Clin Invest 2007; 117(9): 2621-2637.
23. Carlsson S, Midthjell K, Grill V. Influence of family history of diabetes on incidence and prevalence of latent autoimmune diabetes of the adult: results from the Nord-Trondelag Health Study. Diabetes Care 2007; 30(12): 3040-3045.
24. Xiang Y, Zhou P, Li X, et al. Heterogeneity of altered cytokine levels across the clinical spectrum of diabetes in China. Diabetes Care 2011; 34(7): 1639-1641.
25. Qi X, Sun J, Wang J, et al. Prevalence and correlates of latent autoimmune diabetes in adults in Tianjin, China: a population-based cross-sectional study. Diabetes Care 2011; 34(1): 66-70.
26. Park Y, Hong S, Park L, et al. LADA prevalence estimation and insulin dependency during follow-up. Diabetes Metab Res Rev 2011; 27(8): 975-979.
27. Imagawa A, Funahashi T, Nakamura T, et al. Elevated serum concentration of adipose-derived factor, adiponectin, in patients with type 1 diabetes. Diabetes Care 2002; 25(9): 1665-1666.
28. Leth H, Andersen KK, Frystyk J, et al. Elevated levels of high-molecular-weight adiponectin in type 1 diabetes. J Clin Endocrinol Metab 2008; 93(8): 3186-3191.
29. Pfleger C, Mortensen HB, Hansen L, et al. Association of IL-1ra and adiponectin with C-peptide and remission in patients with type 1 diabetes. Diabetes 2008; 57(4): 929-937.
30. Torrens JI, Skurnick J, Davidow AL, et al. Ethnic differences in insulin sensitivity and beta-cell function in premenopausal or early perimenopausal women without diabetes: the Study of Women's Health Across the Nation (SWAN). Diabetes Care 2004; 27(2): 354-361.
31. Tamakoshi K, Yatsuya H, Wada K, et al. The transition to menopause reinforces adiponectin production and its contribution to improvement of insulin-resistant state. Clin Endocrinol (Oxf) 2007; 66(1): 65-71.
32. Zhu N, Pankow JS, Ballantyne CM, et al. High-molecular-weight adiponectin and the risk of type 2 diabetes in the ARIC study. J Clin Endocrinol Metab 2010; 95(11): 5097-5104.